The pulse, right now.
A continuously-updating read on what the AI industry is doing, shipping, buying, and saying.
appeal 9.0Meta AI Agent Progress Slows
Meta CEO Mark Zuckerberg revealed AI agent development has not met internal expectations, despite significant investment and restructuring. This signals persistent technical hurdles for agentic AI, requiring procurement teams to re-evaluate vendor roadmaps and security architects to reinforce human oversight.
The AI landscape is marked by rapid innovation and increasing complexity. While drug discovery and coding assistance see significant AI integration, concerns about development pace, cost control, and ethical deployment …
The stream
- RESEARCHMeta AI Agent Meta AI Agent progress slows9.0
- INVESTMENTChina AI Drug Deals China AI Drug Deals Surge to $75 Billion9.0
- OPENSOURCEGitHub Copilot Adds Open-Weight Model Kimi K2.77.0
- POLICYOpenAI OpenAI Implements Hard API Spending Limits8.0
- FUNDINGSoftBank SoftBank guarantees OpenAI loan8.0
- RESEARCHSamsung Samsung advances quantum AI chipmaking research8.0
- RELEASEGemini Spark Google releases Gemini Spark for Mac7.0
- POLICYCloudflare Cloudflare blocks mixed AI crawlers by default7.0
- RESEARCHAnthropic, Sakana AI, Z.ai AI benchmarks show fragmented leadership8.0
- PRODUCTMeta Meta plans AI compute sales9.0
- INVESTMENTChipmakers Chipmakers add $2 trillion market cap9.0
- POLICYGodot Foundation Godot Foundation Forbids AI Code Contributions8.0
- + more stories in the last 24 hoursAll stories →
Subjects
The AI landscape is marked by rapid innovation and increasing complexity.
A weekly synthesis of the most material AI-industry moves — what shipped, what was bought, what regulators said, and how the pattern is shifting.
Capital availability is no longer the primary constraint — return justification is.
Departments
All stories →
China AI Drug Deals Surge
Chinese AI drug-design firms secured US$75 billion in out-licensing deals with global pharmaceutical companies in early 2026, a sharp rise from previous years. This provides a critical mechanism for pharma R&D teams to replenish pipelines, despite increasing US scrutiny and policy overhangs.
OpenAI Introduces Hard API Spending Limits
OpenAI now provides hard spending limits for its API, allowing users to cap monthly expenditure and prevent unexpected costs from autonomous agent activity. This mechanism helps procurement teams and platform engineers manage financial exposure and operational costs.
SoftBank Guarantees OpenAI Loan
SoftBank is offering a guarantee for a $10 billion loan backed by its OpenAI stake, shifting valuation risk back to the borrower. This illustrates a potential model for private asset-backed financing for large-scale AI investments, increasing scrutiny for founders and investors.
Samsung Advances Quantum AI Chipmaking
Samsung's development of quantum computing and AI for lithography simulations aims to cut chip manufacturing time and cost, while boosting density and yield. This initiative directly challenges established foundry leaders, impacting procurement strategies and investment in advanced silicon production.
Meta Plans AI Compute Sales
Meta's reported plan to launch "Meta Compute" to sell AI compute and models, leveraging its $182.9 billion infrastructure investment, introduces a new hyperscale provider. This diversifies supply for procurement teams and platform engineers, potentially impacting the cost curve for AI development.
Chipmakers Add $2 Trillion, AWS Expands FDE
Investors are broadening AI infrastructure bets, adding $2 trillion to Intel, Micron, and AMD's market cap. AWS's expanded forward-deployed engineering unit intensifies competition for tailored AI solutions, offering procurement teams more hardware options and challenging founders to assess bespoke integration services.
Every Tuesday. 5-minute read. 34,904 unique readers.
A tight brief for CTOs, CFOs, product leads, and founders. No hype. No hedging. No filler.